United Therapeutics: Eyeing A Re-Rating To 12-13x P/E, Growth More Than Justified

Business on Wall Street in Manhattan

Pgiam/iStock via Getty Images

Investment briefing

United Therapeutics Corporation (NASDAQ:NASDAQ:UTHR) pulled in with a strong set of quarterly results before the open yesterday. Following my May profiling of UTHR the company’s equity stock has caught a

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *